Cargando…
Listening understanding and acting (lung): focus on communicational issue in thoracic oncology
BACKGROUND: In the field of oncological assistance, nowadays we have to deal with a complex scenario where patients got used to obtain a huge amount of information through internet or social media and to apply them in performing their health-related decisions. This landscape requires that clinicians...
Autores principales: | Finocchiaro, Claudia Yvonne, Rota, Alessandra, Barbieri, Vito, Bettini, Anna, Bianco, Roberto, Borra, Gloria, Buffoni, Lucio, Bulotta, Alessandra, Carta, Annamaria, Cortinovis, Diego, Costanzo, Raffaele, Cusmai, Antonio, Danesi, Romano, D’Argento, Ettore, Del Conte, Alessandro, Franchina, Tindara, Gilli, Marina, Gregorc, Vanesa, Irtelli, Luciana, Landi, Lorenza, Malorgio, Francesco, Mancuso, Gianfranco, Martelli, Olga, Mazzanti, Paola, Melotti, Barbara, Migliorino, Maria Rita, Minotti, Vincenzo, Montrone, Michele, Morabito, Alessandro, Roca, Elisa, Romano, Giampiero, Rossi, Antonio, Savio, Giuseppa, Tiseo, Marcello, Boscardini, Ivano, Piccolo, Lorenzo, Pilotto, Sara, Malapelle, Umberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798889/ https://www.ncbi.nlm.nih.gov/pubmed/35117061 http://dx.doi.org/10.21037/tcr.2018.12.32 |
Ejemplares similares
-
Heterogeneous Responses to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) in Patients with Uncommon EGFR Mutations: New Insights and Future Perspectives in this Complex Clinical Scenario
por: Russo, Alessandro, et al.
Publicado: (2019) -
Sharing Experience with Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors in Lung Cancer: An Italian Expert Panel Discussion
por: Gridelli, Cesare, et al.
Publicado: (2023) -
Baseline neutrophilia, derived neutrophil‐to‐lymphocyte ratio (dNLR), platelet‐to‐lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel
por: Russo, Alessandro, et al.
Publicado: (2018) -
The use of intravenous versus subcutaneous monoclonal antibodies in the treatment of severe asthma: a review
por: Matucci, Andrea, et al.
Publicado: (2018) -
Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases
por: Ricciardi, Giuseppina Rosaria Rita, et al.
Publicado: (2015)